Recombinant KIR2DL2 (Lirilumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
FACS
Hôte: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits KIR2DL2 (Lirilumab Biosimilar)
- KIR2DL2 (Lirilumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Human
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp KIR2DL2 (Lirilumab Biosimilar) est non-conjugé
-
Application
- Flow Cytometry (FACS)
- Fonction
- Anti-KIR2DL2 (lirilumab biosimilar) mAb
- Attributs du produit
- BMS-986015, IPH2102
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Classe de qualité
- Research Grade
- Isotype
- IgG4
-
-
- Indications d'application
- Flow Cyt 1:100
- Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Date de péremption
- 12 months
-
- Antigène
- KIR2DL2 (Lirilumab Biosimilar)
- Abstract
- KIR2DL2 (Lirilumab Biosimilar) Produits
- Classe de substances
- Biosimilar
- Sujet
- Synonyms: CD158b, CD158B1, NKAT-6, NKAT6, p58.2
- UniProt
- P43627
-
Vous êtes ici:
